Standout Papers

The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adu... 2023 2026 202483
  1. The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials (2023)
    Brandon Essink, Laurence Chu et al. The Lancet Infectious Diseases

Immediate Impact

2 by Nobel laureates 2 from Science/Nature 49 standout
Sub-graph 1 of 22

Citing Papers

Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model
2024 StandoutScience
Agriculture and environmental management through nanotechnology: Eco-friendly nanomaterial synthesis for soil-plant systems, food safety, and sustainability
2024 Standout
2 intermediate papers

Works of Hamilton Bennett being referenced

A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine
2021
Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants
2021

Author Peers

Author Last Decade Papers Cites
Hamilton Bennett 269 53 28 119 59 6 365
Zehan Pang 260 61 24 110 44 7 403
Beng Lee Lim 314 35 10 91 19 6 386
Roderick McPhee 177 38 19 66 48 10 369
Sophia M. Vrba 152 66 8 111 25 10 335
Rosa Isela Gálvez 289 40 6 87 32 12 373
Jayesh Sanmukhani 204 33 10 103 76 10 301
Mallorie E. Fouch 263 38 18 104 9 7 362
Chien-Hsiung Pan 154 219 30 65 41 12 366
Audrey L. Butler 159 56 8 33 47 7 322
Enyue Fang 171 43 23 224 18 9 384

All Works

Loading papers...

Rankless by CCL
2026